<DOC>
	<DOCNO>NCT01654926</DOCNO>
	<brief_summary>Ultrafiltration ( UF ) technology unique ability extract fluid isotonic solution , therefore cause substantial change NaCl concentration , use peripheral vein make feasible use hospital medical center , non compensate Heart Failure ( HF ) low response diuretic . The use UF United States Europe hospital HF center accept daily practice . Therefore hypothesis study feasible professional team effectively use UF short course non compensate HF patient low response Diuretics , dedicate hospital HF center .</brief_summary>
	<brief_title>Feasibility Assessment Aquadex FlexFlowTM Ultrafiltration System Treating Non Hospitalized Heart Failure Patients Dedicated Heart Failure Centers</brief_title>
	<detailed_description>The patient treat LIN Heart Failure Center include population define Exclusion criterion . Up 60 patient recruit one undergo 30 treatment time interval define cardiologist accord clinical need throughout duration study . Inclusion duration every patient terminate end treatment course . No prevention add treatment course per patient accord clinical need upon cardiologist 's decision . Operating UF system : During treatment course two patient 's peripheral vein cannulate . One use draw blood , use return blood back patient . The patient administer Heparin IV , Clexane SC ACT target 180-200 monitored every 4-6 hour . Fluid removal rate accord cardiologist discretion exceed 500 ml/hour Patient monitoring - Pulse BP record baseline , 10 minute treatment onset every 1 hour .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>HF patient peripheral pulmonic fluid retention , little response Diuretics define refer cardiologist 1 . Age &lt; 18 year 2 . Patient fully comprehend Essence study sign inform consent . 3 . Patient participate drug treatment study ( prevention include patient participate study non invasive monitoring technology . 4 . Presence Acute MI 5 . CR base value &gt; 3mg/dl 6 . Hemodynamic instability require Inotropic agent 7 . HT base value &gt; 45 % 8 . Known pregnancy 9 . Presence contraindication anticoagulant 10 . Post heart transplant cardiac assist device implantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Feasibility use FlexFlowTM ultrafiltration pump non hospital environment</keyword>
</DOC>